Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson's Disease Mouse Model
Aging Cell · 2026
DOI: 10.1111/acel.70717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Xuenan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Brain Science and Brain-Inspired Research, Shandong Provincial Key Laboratory of Brain Science, Shandong First Medical University & Shan…. Hauptthemen laut MEDLINE: alpha-Synuclein, Dopaminergic Neurons, Parkinson Disease, Nerve Degeneration. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Parkinson's disease (PD) is characterized by the accumulation of Lewy bodies (LBs) in the brain, predominantly consisting of aggregated and phosphorylated α‐synuclein (α‐Syn). Consequently, strategies to suppress α‐Syn expression offer substantial therapeutic potential for PD. This study explores heteroduplex oligonucleotides (HDOs), an innovative gene‐silencing technology utilizing DNA/RNA or DNA/DNA hybrids. We designed two HDOs targeting α‐Syn: α‐Syn‐HDO‐1 (DNA/RNA) and α‐Syn‐HDO‐2 (DNA/DNA). Both demonstrated robust silencing of α‐Syn expression in mice. In AAV‐hSyn‐human SNCA‐treated mice, these α‐Syn‐HDOs exerted neuroprotective effects on dopaminergic neurons. Furthermore, they reduced aberrant α‐Syn accumulation in α‐Syn‐HEK293 cells and in mice treated with α‐Syn preformed fibrils (PFFs). The neuroprotective effects of α‐Syn‐HDOs were linked to activation of the brain‐derived neurotrophic factor (BDNF)‐tyrosine kinase B (TrkB) signaling pathway. Moreover, BDNF overexpression diminished abnormal α‐Syn aggregation in both PFFs‐treated α‐Syn‐HEK293 cells and PFFs‐treated mice. These results highlight the capacity of α‐Syn‐HDOs to protect dopaminergic neurons by enhancing BDNF–TrkB signaling through the inhibition of abnormal elevated α‐Syn. Our findings position α‐Syn‐HDOs as promising therapeutic candidates for PD and suggest BDNF as a potential diagnostic biomarker or indicator of treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Brain Science and Brain-Inspired Research, Shandong Provincial Key Laboratory of Brain Science, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
- Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
- NHC Key Laboratory of Mental Health (Peking University), and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Sixth Hospital, Peking University Institute of Me…
- Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, China.
ORCID-Profile: Yiru Ding, Lujuan He, Xiwen Geng, Fumika Sakaue, Liang-Wen Zhang, Ji-Chun Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Ding, Y., He, L., Kang, X., Geng, X., Sakaue, F., Yokota, T., Zhang, L. W., Yao, W., & Zhang, J. C. (2026). Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson's Disease Mouse Model. Aging Cell. https://doi.org/10.1111/acel.70717
Vancouver
Wang X, Ding Y, He L, Kang X, Geng X, Sakaue F, et al. Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson's Disease Mouse Model. Aging Cell. 2026. doi:10.1111/acel.70717
BibTeX
@article{Wang2026,
author = {Wang, Xuenan and Ding, Yiru and He, Lujuan and Kang, Xizhi and Geng, Xiwen and Sakaue, Fumika and Yokota, Takanori and Zhang, Liang-Wen and Yao, Wei and Zhang, Ji-Chun},
title = {Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson's Disease Mouse Model},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70717}
}
EUVIMED